First-line systemic treatment strategies in patients with initially unresectable colorectal cancer liver metastases (CAIRO5): an open-label, multicentre, randomised, controlled, phase 3 study from the Dutch Colorectal Cancer Group.
- DOI
- 10.1016/s1470-2045(23)00219-x
- Published
- 2023 Jul
- Container
- The Lancet. Oncology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/s1470-2045-23-00219-x,
title = {First-line systemic treatment strategies in patients with initially unresectable colorectal cancer liver metastases (CAIRO5): an open-label, multicentre, randomised, controlled, phase 3 study from the Dutch Colorectal Cancer Group.},
author = {Bond MJG and Bolhuis K and Loosveld OJL and de Groot JWB and Droogendijk H and Helgason HH and Hendriks MP and Klaase JM and Kazemier G and Liem MSL and Rijken AM and Verhoef C and de Wilt JHW and de Jong KP and Gerhards MF and van Amerongen MJ and Engelbrecht MRW and van Lienden KP and Molenaar IQ and de Valk B and Haberkorn BCM and Kerver ED and Erdkamp F and van Alphen RJ and Mathijssen-van Stein D and Komurcu A and Lopez-Yurda M and Swijnenburg RJ and Punt CJA and Dutch Colorectal Cancer Study Group},
year = {2023},
journal = {The Lancet. Oncology},
doi = {10.1016/s1470-2045(23)00219-x},
url = {https://doi.org/10.1016/s1470-2045(23)00219-x}
}RIS
TY - JOUR TI - First-line systemic treatment strategies in patients with initially unresectable colorectal cancer liver metastases (CAIRO5): an open-label, multicentre, randomised, controlled, phase 3 study from the Dutch Colorectal Cancer Group. AU - Bond MJG AU - Bolhuis K AU - Loosveld OJL AU - de Groot JWB AU - Droogendijk H AU - Helgason HH AU - Hendriks MP AU - Klaase JM AU - Kazemier G AU - Liem MSL AU - Rijken AM AU - Verhoef C AU - de Wilt JHW AU - de Jong KP AU - Gerhards MF AU - van Amerongen MJ AU - Engelbrecht MRW AU - van Lienden KP AU - Molenaar IQ AU - de Valk B AU - Haberkorn BCM AU - Kerver ED AU - Erdkamp F AU - van Alphen RJ AU - Mathijssen-van Stein D AU - Komurcu A AU - Lopez-Yurda M AU - Swijnenburg RJ AU - Punt CJA AU - Dutch Colorectal Cancer Study Group PY - 2023 JO - The Lancet. Oncology DO - 10.1016/s1470-2045(23)00219-x UR - https://doi.org/10.1016/s1470-2045(23)00219-x ER -
APA
MJG, B., K, B., OJL, L., JWB, D. G., H, D., HH, H., MP, H., JM, K., G, K., MSL, L., AM, R., C, V., JHW, D. W., KP, D. J., MF, G., MJ, V. A., MRW, E., KP, V. L., IQ, M., B, D. V., BCM, H., ED, K., F, E., RJ, V. A., D, M. S., A, K., M, L., RJ, S., CJA, P., & Group, D. C. C. S. (2023). First-line systemic treatment strategies in patients with initially unresectable colorectal cancer liver metastases (CAIRO5): an open-label, multicentre, randomised, controlled, phase 3 study from the Dutch Colorectal Cancer Group.. The Lancet. Oncology. https://doi.org/10.1016/s1470-2045(23)00219-x
Source records
- pubmed · retrieved 2026-09-26T00:42:12.671Z